Schedule 13G ownership disclosure

SERES THERAPEUTICS INC

Security class unavailable · CUSIP: 81750R102

Event date: 2019-08-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.1500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-19-005718
Form type
SC 13G
Filer
Seres Therapeutics, Inc.
CIK
CIK 1609809
Filed
Sep 09, 2019
Reporting period
Aug 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub